Search Results 61-70 of 539 for ⚕[돈버는게임:로아월드] 프리베네 린프리 프리베네 투데이프리⚕

  1. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Non Clinical Trials

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  3. A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer - Mayo Clinic

    mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both arms will continue treatment until ...

  5. Leniolisib (oral route) - Side effects & dosage - Mayo Clinic

    Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription ...

  6. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Phone: 855-776-0015 (toll-free). International patient clinical studies questions. Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo ...

  7. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    The study will be conducted in three parts. Part 1 is a dose escalation phase to determine the maximum tolerated dose (MTD) of INCB040093, a PI3Kδ inhibitor, or ...

  8. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

    Additional contact information. Non-cancer trials contact form. Phone: 800-664-4542 (toll-free). International patient clinical studies questions. Phone: 507 ...

  9. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors - Mayo Clinic

    Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for tumor growth and tumor blood vessel growth. Participation ...

  10. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...